Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/127545
Title: Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations
Author: Graus Ribas, Francesc
Saiz Hinajeros, Albert
Lai, Marina
Bruna, Jordi
López, Francisca
Sabater, Lidia
Blanco, Yolanda
Rey, María Jesús
Ribalta Farrés, Teresa María
Dalmau Obrador, Josep
Keywords: Encefalitis
Immunoglobulines
Immunoteràpia
Encephalitis
Immunoglobulins
Immunotheraphy
Issue Date: 16-Sep-2008
Publisher: Lippincott, Williams & Wilkins. Wolters Kluwer Health
Abstract: Objective: To report the frequency and type of antibodies against neuronal surface antigens (NSA-ab) in limbic encephalitis (LE). Methods: Analysis of clinical features, neuropathologic findings, and detection of NSA-ab using immunochemistry on rat tissue and neuronal cultures in a series of 45 patients with paraneoplastic (23) or idiopathic (22) LE. Results: NSA-ab were identified in 29 patients (64%; 12 paraneoplastic, 17 idiopathic). Thirteen patients had voltage-gated potassium channels (VGKC)-ab, 11 novel NSA (nNSA)-ab, and 5 NMDA receptor (NMDAR)-ab. nNSA-ab did not identify a common antigen and were more frequent in paraneoplastic than idiopathic LE (39% vs 9%; p = 0.03). When compared with VGKC-ab or NMDAR-ab, the nNSA associated more frequently with intraneuronal antibodies (11% vs 73%; p = 0.001). Of 12 patients (9 nNSA-ab, 2 VGKC-ab, 1 NMDAR-ab) with paraneoplastic LE and NSA-ab, concomitant intraneuronal antibodies occurred in 9 (75%). None of these 12 patients improved with immunotherapy. The autopsy of three of them showed neuronal loss, microgliosis, and cytotoxic T cell infiltrates in the hippocampus and amygdala. These findings were compatible with a T-cell mediated neuronal damage. In contrast, 13 of 17 (76%) patients with idiopathic LE and NSA-ab (8 VGKC-ab, 4 NMDAR-ab, 1 nNSA-ab) and 1 of 5 (20%) without antibodies had clinical improvement (p = 0.04). Conclusions: In paraneoplastic limbic encephalitis (LE), novel antibodies against neuronal surface antigens (nNSA-ab) occur frequently, coexist with antibodies against intracellular antigens, and these cases are refractory to immunotherapy. In idiopathic LE, the likelihood of improvement is significantly higher in patients with NSA-ab than in those without antibodies.
Note: Reproducció del document publicat a: https://doi.org/10.1212/01.wnl.0000325917.48466.55
It is part of: Neurology, 2008, vol. 71, num. 12, p. 930-936
URI: http://hdl.handle.net/2445/127545
Related resource: https://doi.org/10.1212/01.wnl.0000325917.48466.55
ISSN: 0028-3878
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
612250.pdf2.33 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.